Recro Pharma Inc (REPH):企業の財務・戦略的SWOT分析

◆英語タイトル:Recro Pharma Inc (REPH) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH336048FSA
◆発行会社(調査会社):GlobalData
◆発行日:2020年12月
◆ページ数:52
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥28,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥42,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Recro Pharma Inc (REPH) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Recro Pharma Inc (Recro) provides contract development and manufacturing organization (CDMO) services. The company harnesses formulation capabilities and proprietary delivery technologies for the development, manufacture, and commercialization of pharmaceutical products of its partners. The company manufactures products such as Ritalin LA, Focalin XR, Verelan PM, Verelan SR and Zohydro ER among others for its commercial partners. The company has a manufacturing facility in Gainesville, Georgia, the US. Recro Pharma is headquartered in Malvern, Pennsylvania, the US.

Recro Pharma Inc Key Recent Developments

Dec 16,2020: Recro announces executive changes
Aug 10,2020: Recro reports second quarter 2020 financial results
May 11,2020: Recro reports first quarter 2020 financial results and provides update on COVID-19 response and impact
Apr 07,2020: Recro Pharma receives loan under Paycheck Protection Program
Mar 04,2020: Recro reports financial results for the year ended 2019

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Recro Pharma Inc – Key Facts
Recro Pharma Inc – Key Employees
Recro Pharma Inc – Key Employee Biographies
Recro Pharma Inc – Major Products and Services
Recro Pharma Inc – History
Recro Pharma Inc – Company Statement
Recro Pharma Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Recro Pharma Inc – Business Description
Recro Pharma Inc – Corporate Strategy
Recro Pharma Inc – SWOT Analysis
SWOT Analysis – Overview
Recro Pharma Inc – Strengths
Recro Pharma Inc – Weaknesses
Recro Pharma Inc – Opportunities
Recro Pharma Inc – Threats
Recro Pharma Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Recro Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Recro Pharma Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Recro Pharma Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Dec 16, 2020: Recro announces executive changes
Aug 10, 2020: Recro reports second quarter 2020 financial results
May 11, 2020: Recro reports first quarter 2020 financial results and provides update on COVID-19 response and impact
Apr 07, 2020: Recro Pharma receives loan under Paycheck Protection Program
Mar 04, 2020: Recro reports financial results for the year ended 2019
Nov 21, 2019: Recro completes separation of Baudax Bio and becomes a dedicated contract development and manufacturing organization
Nov 13, 2019: Recro Pharma announces effectiveness of Baudax Bio Form 10 Registration Statement
Nov 08, 2019: Recro Pharma reports third quarter 2019 financial results
Aug 08, 2019: Recro Pharma reports second quarter 2019 financial results
May 10, 2019: Recro Pharma reports first quarter 2019 financial results
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Recro Pharma Inc, Key Facts
Recro Pharma Inc, Key Employees
Recro Pharma Inc, Key Employee Biographies
Recro Pharma Inc, Major Products and Services
Recro Pharma Inc, History
Recro Pharma Inc, Subsidiaries
Recro Pharma Inc, Key Competitors
Recro Pharma Inc, Ratios based on current share price
Recro Pharma Inc, Annual Ratios
Recro Pharma Inc, Annual Ratios (Cont...1)
Recro Pharma Inc, Annual Ratios (Cont...2)
Recro Pharma Inc, Interim Ratios
Recro Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Recro Pharma Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Recro Pharma Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Recro Pharma Inc (REPH):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • American Greetings Corporation:企業の戦略・SWOT・財務情報
    American Greetings Corporation - Strategy, SWOT and Corporate Finance Report Summary American Greetings Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Sopharma AD (3JR):企業の財務・戦略的SWOT分析
    Sopharma AD (3JR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • National Electric Power Co:企業の戦略的SWOT分析
    National Electric Power Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Chiba University:製薬・医療:M&Aディール及び事業提携情報
    Summary Chiba University (Chiba) is an educational university that offers undergraduate education, short-term study program, graduation, double degree program, global COE program, good practice program, distinctive education and research, and international collaborative research program. The univers …
  • Pinsent Masons LLP:企業の戦略的SWOT分析
    Pinsent Masons LLP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Navigo Proteins GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Navigo Proteins GmbH (Navigo Proteins), formerly Scil Proteins GmbH, a subsidiary of UV-Cap GmbH & Co KG, is a protein engineering company that offers generation and optimization of proteins for therapeutic and non-therapeutics. The company provides microbial production of recombinant protei …
  • Bank of India:企業のM&A・事業提携・投資動向
    Bank of India - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Bank of India Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Companhia Riograndense de Mineracao:企業の戦略・SWOT・財務情報
    Companhia Riograndense de Mineracao - Strategy, SWOT and Corporate Finance Report Summary Companhia Riograndense de Mineracao - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • RainDance Technologies Inc:医療機器:M&Aディール及び事業提携情報
    Summary RainDance Technologies Inc (RDT), a subsidiary of Bio-Rad Laboratories Inc is a developer of genomic tools for non-invasive liquid biopsy applications. The company’s products include RainDrop Plus, a digital PCR system that provides picoliter droplets for multiplex detection of HIV and DNA; …
  • Origin Energy Ltd (ORG):企業の財務・戦略的SWOT分析
    Origin Energy Ltd (ORG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • British Business Bank Plc:企業の戦略的SWOT分析
    British Business Bank Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • J.E. Dunn Construction Group, Inc.:企業の戦略的SWOT分析
    J.E. Dunn Construction Group, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • ASX Ltd (ASX):企業の財務・戦略的SWOT分析
    ASX Ltd (ASX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Cidara Therapeutics Inc (CDTX):企業の財務・戦略的SWOT分析
    Summary Cidara Therapeutics Inc (Cidara), formerly K2 Therapeutics Inc is a biotechnology company that discovers, develops and commercializes novel anti-infectives including immunotherapies. The company's pipeline products include CD101 for treatment of invasive fungal disease; and CD377 for treatin …
  • Kiewit Corporation:企業の戦略・SWOT・財務情報
    Kiewit Corporation - Strategy, SWOT and Corporate Finance Report Summary Kiewit Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Ildong Pharmaceutical Co Ltd (000230):企業の財務・戦略的SWOT分析
    Summary Ildong Pharmaceutical Co Ltd (IPC) is a manufacturer of pharmaceutical products. The company offers finished drugs, health foods and foods, raw material drugs, cosmetics and medical devices and others. Its raw material drugs comprise synthesis, probiotics, vitamins and biometabolites. IPC al …
  • Abbott Laboratories (ABT):医療機器:M&Aディール及び事業提携情報
    Summary Abbott Laboratories (Abbott) develops, manufactures, and sells a diversified range of healthcare products including drugs, diagnostics, branded generics, and vascular and nutritional products. The company’s products comprise specialized medicines; medical diagnostic instruments and tests; mi …
  • Territorial Generation Company No. 11:企業の戦略的SWOT分析
    Territorial Generation Company No. 11 - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and maj …
  • American Overseas Group Limited:企業の戦略・SWOT・財務分析
    American Overseas Group Limited - Strategy, SWOT and Corporate Finance Report Summary American Overseas Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Ratnamani Metals and Tubes Ltd:企業の戦略・SWOT・財務情報
    Ratnamani Metals and Tubes Ltd - Strategy, SWOT and Corporate Finance Report Summary Ratnamani Metals and Tubes Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆